BioStock: Cereno Scientific granted IPR protection in Australia

Cereno Scientific continues to solidify its intellectual property rights around lead drug development programme CS1. Yesterday, the biotech company announced being granted a patent expanding the protection of CS1 in the Australian market. This patent is part of the second family of patents related to CS1, which is already covering the US, Russia and Japan.

Read the full article at biostock.se:

https://www.biostock.se/en/cereno-scientific-granted-ipr-protection-in-australia/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se